Page 5 - Oard Recertification News Today

Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to...

To date, the aesthetic needs of Hispanic/Latinx patients, the second largest ethnic group in the United States, have been poorly understood.

The cardiology community mourns the loss of its internationally renowned member, who was equally talented in research and clinical practice.

Projections suggest that by 2030, demand for pediatric rheumatologists in the United States will exceed supply by about 77%.

Data suggest that few immigrants to Canada with tuberculosis infection were infected within the preceding 2 years, when the risk for progression to tuberculosis disease is the highest.

Grappling with a shortage of obesity drugs, doctors find themselves at the forefront of strategic decision-making to ensure optimal patient care.

The average age of death for Black US patients with sickle cell disease rose from 39 years in 1999-2009 to 43 years in 2010-2020, reflecting improvements in treatment.

Harvard economists challenge prevailing narrative shared by hospitals, doctors.

A recent Swiss study, despite having a better methodology than previous research, can do little more than fuel hypotheses.

The proposal by the major cardiovascular societies to form a new certification board represents a revolution in the field of CME and assessment of competency. What is known so far?